"Riding my bike to campus along Delaware or Pennsylvania avenues — especially in the fall when the trees are changing color and form a canopy over the street — reminds ...

Microsoft Research on September 29, 2026, introduced Quine, a research effort built around a multimodal world model of ...

Century Therapeutics' CNTY-813 aims to deliver insulin-producing islets without chronic systemic immunosuppression. Find out ...

Jump Festa 2027 arrives December 19-20 at Makuhari Messe with seven flagship franchises confirmed, and every power system in ...

Explore incredible microscopic details that reveal the complexity of the human body. #Microscope #Science #Biology ...

The initiative aims to take early diagnosis, genetic counselling, and specialised treatment to remote tribal pockets that ...

Agilent Technologies introduces Gen5 AI cell identification module for BioTek automated cell imagers: Santa Clara, California Wednesday, September 30, 2026, 14:00 Hrs [IST] Agilen ...

Menin acts as a molecular brake on pancreatic β- cell proliferation. With its menin inhibitor platform, Caspian is pursuing a ...

A large prospective real-world study in China has confirmed that first-line osimertinib provides substantial clinical benefit to patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), ...

EGL-003, a selective IL-2 agonist, was well tolerated across all four dose cohorts.EGL-003 produced selective, dose-dependent Treg expansion ...

A Fondy player turned his family’s experience with cancer into a tribute that will help patients close to home.

Fenebrutinib is designed to act throughout the body and to cross the blood-brain barrier into the central nervous system to target both the acute inflammation that causes relapses and the chronic ...